D.E. Shaw & Co’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q1 | – | Sell |
-12,220
| Closed | -$154K | – | 2704 |
|
2016
Q4 | $154K | Sell |
12,220
-8,391
| -41% | -$106K | ﹤0.01% | 2375 |
|
2016
Q3 | $377K | Sell |
20,611
-3,889
| -16% | -$71.1K | ﹤0.01% | 2114 |
|
2016
Q2 | $260K | Buy |
24,500
+14,388
| +142% | +$153K | ﹤0.01% | 2301 |
|
2016
Q1 | $191K | Buy |
10,112
+4,940
| +96% | +$93.3K | ﹤0.01% | 2402 |
|
2015
Q4 | $138K | Buy |
+5,172
| New | +$138K | ﹤0.01% | 2500 |
|
2015
Q3 | – | Sell |
-1,313
| Closed | -$42K | – | 2807 |
|
2015
Q2 | $42K | Buy |
+1,313
| New | +$42K | ﹤0.01% | 2581 |
|
2015
Q1 | – | Sell |
-1,564
| Closed | -$59K | – | 2751 |
|
2014
Q4 | $59K | Buy |
+1,564
| New | +$59K | ﹤0.01% | 2431 |
|
2014
Q3 | – | Sell |
-552
| Closed | -$16K | – | 2710 |
|
2014
Q2 | $16K | Buy |
+552
| New | +$16K | ﹤0.01% | 2311 |
|
2013
Q4 | – | Sell |
-1,331
| Closed | -$71K | – | 2710 |
|
2013
Q3 | $71K | Buy |
+1,331
| New | +$71K | ﹤0.01% | 2319 |
|